BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31808149)

  • 1. Nonbreast cancer incidence, treatment received and outcomes: Are there differences in breast screening attendees versus nonattendees?
    Walpole E; Dunn N; Youl P; Harden H; Furnival C; Moore J; Taylor K; Evans E; Philpot S
    Int J Cancer; 2020 Aug; 147(3):856-865. PubMed ID: 31808149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast-cancer mortality in screened versus unscreened women: Long-term results from a population-based study in Queensland, Australia.
    Dunn N; Youl P; Moore J; Harden H; Walpole E; Evans E; Taylor K; Philpot S; Furnival C
    J Med Screen; 2021 Jun; 28(2):193-199. PubMed ID: 32842857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.
    Webb ML; Cady B; Michaelson JS; Bush DM; Calvillo KZ; Kopans DB; Smith BL
    Cancer; 2014 Sep; 120(18):2839-46. PubMed ID: 24018987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Report of Cancer Incidence and Mortality in China, 2014].
    Chen WQ; Li H; Sun KX; Zheng RS; Zhang SW; Zeng HM; Zou XN; Gu XY; He J
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):5-13. PubMed ID: 29365411
    [No Abstract]   [Full Text] [Related]  

  • 6. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.
    Tabar L; Yen MF; Vitak B; Chen HH; Smith RA; Duffy SW
    Lancet; 2003 Apr; 361(9367):1405-10. PubMed ID: 12727392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide screening program for breast and cervical cancers in Hungary: special challenges, outcomes, and the role of the primary care provider.
    Kolozsvári LR; Langmár Z; Rurik I
    Eur J Gynaecol Oncol; 2013; 34(5):419-24. PubMed ID: 24475575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of screening on cancer incidence and mortality in Missouri, USA, 2004-2013.
    Yoshida Y; Schmaltz CL; Jackson-Thompson J; Simoes EJ
    Public Health; 2018 Jan; 154():51-58. PubMed ID: 29197686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States.
    Richman IB; Long JB; Soulos PR; Wang SY; Gross CP
    Ann Intern Med; 2023 Sep; 176(9):1172-1180. PubMed ID: 37549389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.
    Bonafede MM; Miller JD; Pohlman SK; Troeger KA; Sprague BL; Herschorn SD; Winer IH
    Am J Prev Med; 2019 Sep; 57(3):394-402. PubMed ID: 31377088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study.
    Kalager M; Haldorsen T; Bretthauer M; Hoff G; Thoresen SO; Adami HO
    Breast Cancer Res; 2009; 11(4):R44. PubMed ID: 19575807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical and Breast Cancer Screening After CARES: A Community Program for Immigrant and Marginalized Women.
    Dunn SF; Lofters AK; Ginsburg OM; Meaney CA; Ahmad F; Moravac MC; Nguyen CTJ; Arisz AM
    Am J Prev Med; 2017 May; 52(5):589-597. PubMed ID: 28094134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing harms and benefits of service mammography screening programs: a cohort study.
    Puliti D; Miccinesi G; Zappa M; Manneschi G; Crocetti E; Paci E
    Breast Cancer Res; 2012 Jan; 14(1):R9. PubMed ID: 22230345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic survey of four thousand patients with 10 common cancers in North Eastern Iran over the past three decades.
    Nikfarjam Z; Massoudi T; Salehi M; Salehi M; Khoshroo F
    Asian Pac J Cancer Prev; 2014; 15(23):10193-8. PubMed ID: 25556447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women.
    Duffy SW; Tabár L; Yen AM; Dean PB; Smith RA; Jonsson H; Törnberg S; Chen SL; Chiu SY; Fann JC; Ku MM; Wu WY; Hsu CY; Chen YC; Svane G; Azavedo E; Grundström H; Sundén P; Leifland K; Frodis E; Ramos J; Epstein B; Åkerlund A; Sundbom A; Bordás P; Wallin H; Starck L; Björkgren A; Carlson S; Fredriksson I; Ahlgren J; Öhman D; Holmberg L; Chen TH
    Cancer; 2020 Jul; 126(13):2971-2979. PubMed ID: 32390151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
    Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.
    Barlow WE; Beaber EF; Geller BM; Kamineni A; Zheng Y; Haas JS; Chao CR; Rutter CM; Zauber AG; Sprague BL; Halm EA; Weaver DL; Chubak J; Doria-Rose VP; Kobrin S; Onega T; Quinn VP; Schapira MM; Tosteson ANA; Corley DA; Skinner CS; Schnall MD; Armstrong K; Wheeler CM; Silverberg MJ; Balasubramanian BA; Doubeni CA; McLerran D; Tiro JA
    J Natl Cancer Inst; 2020 Mar; 112(3):238-246. PubMed ID: 31292633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.
    Niraula S; Biswanger N; Hu P; Lambert P; Decker K
    JAMA Netw Open; 2020 Sep; 3(9):e2018179. PubMed ID: 32975573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.